{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:12:48Z","timestamp":1789744368533,"version":"4.0.1"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:sec id=\"ab-ooi230031-4\"><jats:title>Importance<\/jats:title><jats:p>Cardiovascular (CV) disease is a substantial cause of morbidity and mortality in cancer due to shared risk factors and exposure to potentially cardiotoxic cancer therapy. However, our understanding of CV risk in patients with head and neck squamous cell carcinoma (HNSCC) is limited.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi230031-5\"><jats:title>Objective<\/jats:title><jats:p>To define CV risk profiles, incident stroke, myocardial infarction (MI), and mortality in patients with HNSCC.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi230031-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This retrospective, population-based cohort study included 35\u202f897 US veterans with newly diagnosed HNSCC from January 1, 2000, to December 31, 2020. Data were analyzed from May 2022 to January 2023.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi230031-7\"><jats:title>Exposures<\/jats:title><jats:p>Demographic, cancer-specific, and treatment characteristics.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi230031-8\"><jats:title>Main Outcomes<\/jats:title><jats:p>Prevalence of CV risk factors, medication use, and control at HNSCC diagnosis; cumulative incidence of stroke and MI; and all-cause death.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi230031-9\"><jats:title>Results<\/jats:title><jats:p>Of 35\u202f857 US veterans with HNSCC (median [IQR] age, 63 [58-69] years; 176 [0.5%] American Indian or Alaska Native, 57 [0.2%] Asian, 5321 [16.6%] Black, 207 [0.6%] Native Hawaiian or Other Pacific Islander, and 26\u202f277 [82.0%] White individuals), there were high rates of former or current smoking (16\u202f341 [83%]), hypertension (24\u202f023 [67%]), diabetes (7988 [22%]), and hyperlipidemia (18\u202f421 [51%]). Although most patients were taking risk-lowering medications, 15\u202f941 (47%) had at least 1 uncontrolled CV risk factor. Black race was associated with increased risk of having uncontrolled CV risk factor(s) (relative risk, 1.06; 95% CI, 1.03-1.09), and patients with larynx cancer had higher rates of prevalent and uncontrolled risk factors compared with other cancer subsites. Considering death as a competing risk, the 10-year cumulative incidence of stroke and MI was 12.5% and 8.3%, respectively. In cause-specific hazards models, hypertension, diabetes, carotid artery stenosis, coronary artery disease, and presence of uncontrolled CV risk factor(s) were significantly associated with stroke and MI. In extended Cox models, incident stroke and MI were associated with a 47% (95% CI, 41%-54%) and 71% (95% CI, 63%-81%) increased risk of all-cause death, respectively.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi230031-10\"><jats:title>Conclusion<\/jats:title><jats:p>The results of this cohort study suggest that in HNSCC, the burden of suboptimally controlled CV risk factors and incident risk of stroke and MI are substantial. Modifiable CV risk factors are associated with risk of adverse CV events, and these events are associated with a higher risk of death. These findings identify populations at risk and potentially underscore the importance of modifiable CV risk factor control and motivate strategies to reduce CV risk in HNSCC survivorship care.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaoto.2023.1342","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T04:34:57Z","timestamp":1687581297000},"page":"717","source":"Crossref","is-referenced-by-count":31,"title":["Risk of Cardiovascular Events Among Patients With Head and Neck Cancer"],"prefix":"10.1001","volume":"149","author":[{"given":"Lova","family":"Sun","sequence":"first","affiliation":[{"name":"Division of Hematology Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Brody","sequence":"additional","affiliation":[{"name":"Division of Otorhinolaryngology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"},{"name":"Corporal Michael Crescenz VA Medical Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Candelieri","sequence":"additional","affiliation":[{"name":"VA Salt Lake City Health Care System, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Lynch","sequence":"additional","affiliation":[{"name":"VA Salt Lake City Health Care System, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger B.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly D.","family":"Getz","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Ky","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"ooi230031r1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.v72.1","article-title":"Cancer statistics, 2022.","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"ooi230031r2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1200\/JCO.2008.20.9288","article-title":"Predictors of competing mortality in advanced head and neck cancer.","volume":"28","author":"Mell","year":"2010","journal-title":"J Clin Oncol"},{"issue":"26","key":"ooi230031r3","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1200\/JCO.2011.35.7301","article-title":"Population-based study of competing mortality in head and neck cancer.","volume":"29","author":"Rose","year":"2011","journal-title":"J Clin Oncol"},{"issue":"10","key":"ooi230031r4","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/cncr.28588","article-title":"Causes of death in long-term survivors of head and neck cancer.","volume":"120","author":"Baxi","year":"2014","journal-title":"Cancer"},{"issue":"7","key":"ooi230031r5","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998.","volume":"109","author":"Fuller","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"ooi230031r6","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1158\/1078-0432.CCR-03-1077","article-title":"Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy.","volume":"10","author":"Argiris","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"15","key":"ooi230031r7","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1200\/JCO.2018.36.15_suppl.6051","article-title":"Cardiovascular disease risks among head and neck cancer survivors in a large, population-based cohort study.","volume":"36","author":"Wei","year":"2018","journal-title":"J Clin Oncol"},{"issue":"31","key":"ooi230031r8","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1200\/JCO.2008.16.6546","article-title":"Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy.","volume":"26","author":"Smith","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"ooi230031r9","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1038\/s41598-021-83665-4","article-title":"The incidence of myocardial infarction and stroke in head and neck cancer patients.","volume":"11","author":"Kwon","year":"2021","journal-title":"Sci Rep"},{"issue":"11","key":"ooi230031r10","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer.","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"ooi230031r11","first-page":"212","article-title":"Comparing the smoking behavior of veterans and nonveterans.","volume":"112","author":"McKinney","year":"1997","journal-title":"Public Health Rep"},{"issue":"2","key":"ooi230031r12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1158\/1055-9965.EPI-08-0347","article-title":"Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.","volume":"18","author":"Hashibe","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"ooi230031r13","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/s41416-020-01031-z","article-title":"Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration.","volume":"123","author":"Di Credico","year":"2020","journal-title":"Br J Cancer"},{"issue":"8","key":"ooi230031r14","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/aje\/kwp222","article-title":"Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies.","volume":"170","author":"Lubin","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"1","key":"ooi230031r15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma.","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"ooi230031r16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer.","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"ooi230031r17","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1186\/s12885-020-07427-7","article-title":"Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.","volume":"20","author":"Elhalawani","year":"2020","journal-title":"BMC Cancer"},{"issue":"9","key":"ooi230031r18","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/hed.v37.9","article-title":"Oropharyngeal squamous cell carcinoma in the veteran population: Association with traditional carcinogen exposure and poor clinical outcomes.","volume":"37","author":"Sandulache","year":"2015","journal-title":"Head Neck"},{"issue":"2","key":"ooi230031r19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/hed.v36.2","article-title":"Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy.","volume":"36","author":"Dorth","year":"2014","journal-title":"Head Neck"},{"issue":"1","key":"ooi230031r20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1200\/JCO.2002.20.1.282","article-title":"Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years.","volume":"20","author":"Dorresteijn","year":"2002","journal-title":"J Clin Oncol"},{"issue":"8","key":"ooi230031r21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1001\/jamaoto.2022.1327","article-title":"Association between up-front surgery and risk of stroke in US veterans with oropharyngeal carcinoma.","volume":"148","author":"Sun","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"9","key":"ooi230031r22","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1161\/STROKEAHA.111.615203","article-title":"Ischemic stroke and transient ischemic attack after head and neck radiotherapy: a review.","volume":"42","author":"Plummer","year":"2011","journal-title":"Stroke"},{"issue":"13","key":"ooi230031r23","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.115.018347","article-title":"Vascular toxicities of cancer therapies: the old and the new\u2014an evolving avenue.","volume":"133","author":"Herrmann","year":"2016","journal-title":"Circulation"},{"issue":"6","key":"ooi230031r24","doi-asserted-by":"publisher","first-page":"OD05","DOI":"10.7860\/JCDR\/2017\/25546.10025","article-title":"Cisplatin induced acute myocardial infarction and dyslipidemia.","volume":"11","author":"Hanchate","year":"2017","journal-title":"J Clin Diagn Res"},{"issue":"9","key":"ooi230031r25","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006453","article-title":"Human papillomavirus status and the risk of cerebrovascular events following radiation therapy for head and neck cancer.","volume":"6","author":"Addison","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"ooi230031r26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/hed.v39.3","article-title":"Cardiovascular risk and prevention in patients with head and neck cancer treated with radiotherapy.","volume":"39","author":"Okoye","year":"2017","journal-title":"Head Neck"},{"key":"ooi230031r27","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1024846","article-title":"Traditional risk factors and cancer-related factors associated with cardiovascular disease risk in head and neck cancer patients.","volume":"9","author":"Mukherjee","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"23","key":"ooi230031r28","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1182\/blood-2012-06-437178","article-title":"Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.","volume":"120","author":"Armenian","year":"2012","journal-title":"Blood"},{"issue":"29","key":"ooi230031r29","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","article-title":"Modifiable risk factors and major cardiac events among adult survivors of childhood cancer.","volume":"31","author":"Armstrong","year":"2013","journal-title":"J Clin Oncol"},{"issue":"6","key":"ooi230031r30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/qjmed\/hcv120","article-title":"Do traditional risk stratification models for cerebrovascular events apply in irradiated head and neck cancer patients?","volume":"109","author":"Gujral","year":"2016","journal-title":"QJM"},{"issue":"4-5","key":"ooi230031r31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1053\/j.seminoncol.2019.10.001","article-title":"Utilization of the Veterans Affairs central cancer registry to evaluate lung cancer outcomes.","volume":"46","author":"Klein","year":"2019","journal-title":"Semin Oncol"},{"issue":"11","key":"ooi230031r32","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/jamaoto.2022.2791","article-title":"Cetuximab-based vs carboplatin-based chemoradiotherapy for patients with head and neck cancer.","volume":"148","author":"Sun","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"10","key":"ooi230031r33","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1097\/QAD.0b013e32832bd7af","article-title":"HIV infection and the risk of diabetes mellitus.","volume":"23","author":"Butt","year":"2009","journal-title":"AIDS"},{"issue":"2","key":"ooi230031r34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/QAI.0000000000000419","article-title":"HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction.","volume":"68","author":"Paisible","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"ooi230031r35","doi-asserted-by":"publisher","first-page":"e210070","DOI":"10.1001\/jamanetworkopen.2021.0070","article-title":"Assessment and management of cardiovascular risk factors among US veterans with prostate cancer.","volume":"4","author":"Sun","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"ooi230031r36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ahj.2014.09.014","article-title":"Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for stroke.","volume":"169","author":"Navar-Boggan","year":"2015","journal-title":"Am Heart J"},{"issue":"2","key":"ooi230031r37","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/EDE.0b013e3182821e75","article-title":"Validation of VA administrative data algorithms for identifying cardiovascular disease hospitalization.","volume":"24","author":"Niesner","year":"2013","journal-title":"Epidemiology"},{"issue":"4","key":"ooi230031r38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.v30.4","article-title":"Multiple imputation using chained equations: issues and guidance for practice.","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"23","key":"ooi230031r39","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association.","volume":"58","author":"Smith","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"ooi230031r40","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hed.v44.7","article-title":"Racial and rural-urban disparities in cardiovascular risk factors among patients with head and neck cancer in a clinical cohort.","volume":"44","author":"Mukherjee","year":"2022","journal-title":"Head Neck"},{"issue":"5","key":"ooi230031r41","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/aje\/kwt029","article-title":"Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.","volume":"178","author":"Wyss","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"2","key":"ooi230031r42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/1747493016670175","article-title":"Hyperlipidemia is associated with lower risk of poststroke mortality independent of statin use: a population-based study.","volume":"12","author":"Yeramaneni","year":"2017","journal-title":"Int J Stroke"},{"issue":"12","key":"ooi230031r43","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/jnci\/djy072","article-title":"Prognostic role of p16 in nonoropharyngeal head and neck cancer.","volume":"110","author":"Bryant","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"ooi230031r44","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1001\/jamaoto.2015.1447","article-title":"Characteristics of human papillomavirus\u2013associated head and neck cancers in a veteran population.","volume":"141","author":"Shay","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ooi230031r45","author":"US Centers for Disease and Prevention"}],"container-title":["JAMA Otolaryngology\u2013Head &amp; Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2805942\/jamaotolaryngology_sun_2023_oi_230031_1691528809.02069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T15:15:59Z","timestamp":1691680559000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2805942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2023.1342","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}